MeSH Browser

MeSH Supplementary: nafamostat
Unique ID: C032855
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C032855
Entry Term(s): 6'-amidino-2-naphthyl 4-guanidinobenzoate; 6'-amidino-2-naphthyl 4-guanidinobenzoate, dimethanesulfonate; Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester; Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester, dihydrochloride; Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester, dimethanesulfonate; CKD-314; CKD314; FUT 175; FUT-175; Ronastat; nafamostat dihydrochloride; nafamostat mesilate; nafamostat mesylate; nafamstat mesilate
Pharm Action: Anti-Inflammatory Agents, Non-Steroidal
Anticoagulants
Protease Inhibitors
Trypsin Inhibitors
Serine Proteinase Inhibitors
Complement Inactivating Agents
Registry Number: Y25LQ0H97D
Related Numbers: 1D2T74921W; 80251-32-7; 81525-10-2
Heading Mapped to: *Benzamidines; *Guanidines
Frequency: 600
Note: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Source: Biochim Biophys Acta 1981;661(2):342
Indexing Information: Fibrinolysin; Kallikreins
Date of Entry: 1982/01/04
Revision Date: 2021/05/05

nafamostat MeSH Supplementary Concept Data 2024